Align Technology Inc (ALGN)
257.65
+1.15
(+0.45%)
USD |
NASDAQ |
May 31, 16:00
255.95
-1.70
(-0.66%)
Pre-Market: 20:00
Align Technology SG&A Expense (Annual): 1.703B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.703B |
| December 31, 2022 | 1.674B |
| December 31, 2021 | 1.709B |
| December 31, 2020 | 1.201B |
| December 31, 2019 | 1.072B |
| December 31, 2018 | 852.40M |
| December 31, 2017 | 665.78M |
| December 31, 2016 | 490.65M |
| December 31, 2015 | 390.24M |
| December 31, 2014 | 332.07M |
| December 31, 2013 | 292.80M |
| December 31, 2012 | 251.34M |
| December 31, 2011 | 233.77M |
| Date | Value |
|---|---|
| December 31, 2010 | 170.14M |
| December 31, 2009 | 243.93M |
| December 31, 2008 | 177.22M |
| December 31, 2007 | 151.51M |
| December 31, 2006 | 160.64M |
| December 31, 2005 | 122.31M |
| December 31, 2004 | 89.78M |
| December 31, 2003 | 77.98M |
| December 31, 2002 | 84.58M |
| December 31, 2001 | 83.10M |
| December 31, 2000 | 58.44M |
| December 31, 1999 | 9.162M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.072B
Minimum
2019
1.709B
Maximum
2021
1.472B
Average
1.674B
Median
2022
SG&A Expense (Annual) Benchmarks
| Boston Scientific Corp | 5.19B |
| ResMed Inc | 874.00M |
| Stryker Corp | 7.129B |
| Edwards Lifesciences Corp | 1.823B |
| Zimmer Biomet Holdings Inc | 2.839B |